Log In
Print
BCIQ
Print
Print this Print this
 

CALY-002

  Manage Alerts
Collapse Summary General Information
Company iDD Biotech
DescriptionHumanized mAb against undisclosed target
Molecular Target Undisclosed
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationCeliac disease
Indication DetailsTreat Type II refractory Celiac disease
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today